Podcast DC Decoded: How Section 232 Tariffs and FDA Upheaval Are Reshaping US Contract Manufacturing with Gil Roth and Marta Wosińska 9 November 2026
Policy Briefing Section 232 Pharma Tariffs Expand Today: What Manufacturers Need to Know 29 September 2026
Podcast Tariffs, FDA Chaos, and BioSecure in Limbo: How CDMOs Should Operate Under Uncertainty 28 June 2026
Content The Politics Behind the Pipeline: How MFN Pricing and Tariffs Are Reshaping Pharma’s Global Strategy 8 June 2026
